>

Virtus LifeSci Profile

BBC

Performance

6 / 100

Odds of Distress

Analyze Filter   Check how we calculate scores
Equity ratings for Virtus LifeSci Biotech Clinical are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 29, 2019 and ending today February 27, 2020. Click here to learn more.

Virtus LifeSci Profile

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Virtus LifeSci is traded on BATS Exchange in USA. more on Virtus LifeSci
Legal NameVirtus LifeSci Biotech Clinical
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
IssuerVirtus
DescriptionVirtus LifeSci Biotech Clinical Trials ETF
Inception Date2014-12-16
BenchmarkLifeSci Biotechnology Clinical Trials Index
Entity TypeRegulated Investment Company
Asset Under Management36.28 Million
Average Trading Valume16,090.6
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End31-Oct
ExchangeNYSE Arca, Inc.
Number of Constituents98.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79
Nav Price37.8
Two Hundred Day Average30.85
Ytd-7.00%
Average Daily Volume In Three Month31.91k
Fifty Two Week Low22.92
As Of DateJanuary 31, 2020
Average Daily Volume Last 10 Day9.86k
Fifty Two Week High40.19
One Month-7.00%
Fifty Day Average37.4
Three Month34.17%
Virtus LifeSci Biotech Clinical [BBC] is traded in USA and was established 2014-12-16. The fund is classified under Health category within Virtus family. Virtus LifeSci Biotech currently have 35.48 M in assets under management (AUM). , while the total return for the last 3 years was 21.71%.
Check Virtus LifeSci Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

Virtus LifeSci Target Price Odds Analysis

Odds Below 36.27HorizonTargetOdds Above 36.27
52.19%30 days 36.27 47.63%
Based on normal probability distribution, the odds of Virtus LifeSci to move above current price in 30 days from now is about 47.63 (This Virtus LifeSci Biotech Clinical probability density function shows the probability of Virtus LifeSci Etf to fall within a particular range of prices over 30 days) .

Virtus LifeSci Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Royal Bank Of CanadaFund Units116.9 K4.5 M
View Virtus LifeSci Diagnostics

Virtus LifeSci Biotech Risk Profiles

Virtus LifeSci Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Virtus LifeSci Biotech Tanh Of Price Series is a hyperbolic price transformation function. View also all equity analysis or get more info about tanh of price series math transform indicator.

Virtus LifeSci Against Markets

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
All  Next Launch Module
Continue to Trending Equities. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Company logos by clearbit